Page 78 - Read Online

Page 30 of 35 Boyajian et al. Microbiome Res Rep 2024;3:29 https://dx.doi.org/10.20517/mrr.2024.05

94. Frommherz L, Bub A, Hummel E, et al. Age-related changes of plasma bile acid concentrations in healthy adults--results from the
cross-sectional KarMeN study. PLoS One 2016;11:e0153959. DOI PubMed PMC
95. Badal VD, Vaccariello ED, Murray ER, et al. The gut microbiome, aging, and longevity: a systematic review. Nutrients
2020;12:3759. DOI PubMed PMC
96. Hersoug LG, Møller P, Loft S. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and
pyroptosis during obesity. Nutr Res Rev 2018;31:153-63. DOI PubMed
97. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J
Clin Invest 2006;116:3015-25. DOI PubMed PMC
98. Ghosh AK, O'Brien M, Mau T, Yung R. Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in
aging. Aging 2017;9:1971-82. DOI PubMed PMC
99. Tilves CM, Zmuda JM, Kuipers AL, et al. Association of lipopolysaccharide-binding protein with aging-related adiposity change and
prediabetes among African ancestry men. Diabetes Care 2016;39:385-91. DOI PubMed PMC
100. Liu X, Lu L, Yao P, et al. Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective
study among middle-aged and older Chinese. Diabetologia 2014;57:1834-41. DOI
101. Gomes JMG, Costa JA, Alfenas RCG. Metabolic endotoxemia and diabetes mellitus: a systematic review. Metabolism 2017;68:133-
44. DOI PubMed
102. Kavanagh K, Hsu FC, Davis AT, Kritchevsky SB, Rejeski WJ, Kim S. Biomarkers of leaky gut are related to inflammation and
reduced physical function in older adults with cardiometabolic disease and mobility limitations. Geroscience 2019;41:923-33. DOI
PubMed PMC
103. Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 2019;16:180. DOI PubMed PMC
104. Marizzoni M, Cattaneo A, Mirabelli P, et al. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and
amyloid pathology in Alzheimer’s disease. J Alzheimers Dis 2020;78:683-97. DOI PubMed
105. Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in
Alzheimer’s disease. Life Sci 2021;264:118627. DOI PubMed
106. Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic
review. Acta Neuropathol Commun 2023;11:42. DOI PubMed PMC
107. Serrano-Pozo A, Muzikansky A, Gómez-Isla T, et al. Differential relationships of reactive astrocytes and microglia to fibrillar
amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol 2013;72:462-71. DOI PubMed PMC
108. Ahmad MH, Fatima M, Mondal AC. Role of hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis and insulin
signaling in the pathophysiology of Alzheimer’s disease. Neuropsychobiology 2019;77:197-205. DOI PubMed
109. Werdermann M, Berger I, Scriba LD, et al. Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function
in a hyperactive state. Mol Metab 2021;43:101112. DOI PubMed PMC
110. Browning KN, Verheijden S, Boeckxstaens GE. The vagus nerve in appetite regulation, mood, and intestinal inflammation.
Gastroenterology 2017;152:730-44. DOI PubMed PMC
111. Sen T, Cawthon CR, Ihde BT, et al. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav
2017;173:305-17. DOI PubMed PMC
112. Phillips RJ, Walter GC, Powley TL. Age-related changes in vagal afferents innervating the gastrointestinal tract. Auton Neurosci
2010;153:90-8. DOI PubMed PMC
113. Han Y, Wang B, Gao H, et al. Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and
neurodegenerative diseases. J Inflamm Res 2022;15:6213-30. DOI PubMed PMC
114. Marsh SE, Blurton-Jones M. Examining the mechanisms that link β-amyloid and α-synuclein pathologies. Alzheimers Res Ther
2012;4:11. DOI PubMed PMC
115. Garvey WT, Mechanick JI, Brett EM, et al; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American association
of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of
patients with obesity. Endocr Pract 2016;22:1-203. DOI PubMed
116. Hernández-Reyes A, Cámara-Martos F, Molina-Luque R, Romero-Saldaña M, Molina-Recio G, Moreno-Rojas R. Changes in body
composition with a hypocaloric diet combined with sedentary, moderate and high-intense physical activity: a randomized controlled
trial. BMC Womens Health 2019;19:167. DOI PubMed PMC
117. Chao AM, Quigley KM, Wadden TA. Dietary interventions for obesity: clinical and mechanistic findings. J Clin Invest
2021;131:140065. DOI PubMed PMC
118. Di Rosa C, Lattanzi G, Spiezia C, et al. Mediterranean diet versus very low-calorie ketogenic diet: effects of reaching 5% body
weight loss on body composition in subjects with overweight and with obesity-a cohort study. Int J Environ Res Public Health
2022;19:13040. DOI PubMed PMC
119. Bruci A, Tuccinardi D, Tozzi R, et al. Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with
obesity and mild kidney failure. Nutrients 2020;12:333. DOI PubMed PMC
120. Dong TS, Luu K, Lagishetty V, et al. A high protein calorie restriction diet alters the gut microbiome in obesity. Nutrients
2020;12:3221. DOI PubMed PMC
121. Tettamanzi F, Bagnardi V, Louca P, et al. A high protein diet is more effective in improving insulin resistance and glycemic
variability compared to a mediterranean diet-a cross-over controlled inpatient dietary study. Nutrients 2021;13:4380. DOI PubMed